Odutola, A., Owolabi, O., Owiafe, P., Mcshane, H., & Ota, M. (2012). A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.
Chicago-referens (17:e uppl.)Odutola, A., O. Owolabi, P. Owiafe, H. Mcshane, och M. Ota. A New TB Vaccine, MVA85A, Induces Durable Antigen-specific Responses 14 Months After Vaccination in African Infants. 2012.
MLA-referens (9:e uppl.)Odutola, A., et al. A New TB Vaccine, MVA85A, Induces Durable Antigen-specific Responses 14 Months After Vaccination in African Infants. 2012.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.